Research Report Screener Results

Chart, Financials, Historical Prices, Reports, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 9 of 9)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
6-Feb-10 Reuters Investment Profile N/A Allon Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for NPC: the economy's impact on NPC's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
27-Jan-10 Versant Partners Douglas Loe Discontinuing research coverage of Allon Therapeutics 2 $10 View Abstract
13-Jan-10 RiskMetrics Group N/A ISS Report on Nuveen Insured California Premium Income Municipal Fund, Inc. 12 $135 View Abstract
13-Jan-10 RiskMetrics Group N/A ISS Report on Nuveen Insured California Premium Income Municipal Fund, Inc. 12 $135 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
28-Mar-09 Standard & Poor's Factual Report N/A Nuveen Ins CA Prem Inc Muni 3 $35 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala NUVEEN INSURED CA PREMIUM INCM MUNI (NPC=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala NUVEEN INSURED CA PREMIUM INCM MUNI (NPC=US) 2-weeks forecast 1 $10 View Abstract

Brokerage Reports (Showing 1 to 1 of 1)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
27-Jan-10 Versant Partners Douglas Loe Discontinuing research coverage of Allon Therapeutics 2 $10 View Abstract

Independent Reports (Showing 1 to 8 of 8)

Release
Date Contributor Author Title Pages Price More Info
6-Feb-10 Reuters Investment Profile N/A Allon Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 12 $20 View Abstract
2-Feb-10 EconomicInvestor N/A "The Economy Matters" Report for NPC: the economy's impact on NPC's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract
13-Jan-10 RiskMetrics Group N/A ISS Report on Nuveen Insured California Premium Income Municipal Fund, Inc. 12 $135 View Abstract
13-Jan-10 RiskMetrics Group N/A ISS Report on Nuveen Insured California Premium Income Municipal Fund, Inc. 12 $135 View Abstract
30-Mar-09 ValuEngine, Inc. N/A ValuEngine Industry Report for DRUGS 18 $49 View Abstract
28-Mar-09 Standard & Poor's Factual Report N/A Nuveen Ins CA Prem Inc Muni 3 $35 View Abstract
28-Mar-09 Pechala's Reports Frantisek Pechala NUVEEN INSURED CA PREMIUM INCM MUNI (NPC=US) 12-months forecast 1 $15 View Abstract
28-Mar-09 Pechala's Reports Lubomir Pechala NUVEEN INSURED CA PREMIUM INCM MUNI (NPC=US) 2-weeks forecast 1 $10 View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.